What Sexually Transmitted Diseases Cause Prostatitis?

Several sexually transmitted infections can trigger inflammation in the prostate gland, a condition broadly called prostatitis. The most well-documented culprits are Chlamydia trachomatis, Trichomonas vaginalis, Mycoplasma genitalium, Neisseria gonorrhoeae (the bacterium behind gonorrhea), and herpes simplex virus. Each of these organisms reaches the prostate through a different route and causes trouble in its own way, which partly explains why STI-related prostatitis is often misdiagnosed or missed entirely.

Chlamydia Trachomatis

Chlamydia is probably the most studied sexually transmitted cause of chronic prostatitis. It is also one of the most common STIs worldwide, which means it gets plenty of opportunities to reach the prostate. The bacterium typically starts as a urethral infection and can ascend into the prostate, where it sets up shop inside the tissue. Researchers have detected chlamydia DNA directly in prostate gland tissue from men with chronic prostatitis, suggesting the organism does not just pass through but actively colonizes the gland.¹ Animal studies have shown that chlamydial species ramp up inflammatory signaling in prostate tissue, driving the kind of persistent low-grade inflammation that becomes chronic prostatitis.²

What makes chlamydia-driven prostatitis particularly frustrating is its tendency to recur. A prospective study that followed men with chronic bacterial prostatitis for an average of about three and a half years found that those whose prostatitis was caused by chlamydia had significantly more symptomatic flare-ups than men whose prostatitis was caused by common urinary bacteria. The chlamydia group averaged around four episodes over the follow-up period compared to roughly three in the non-chlamydia group, and their first recurrence came sooner, at about three months versus nearly six months.³ That pattern matters because it means men with chlamydia-related prostatitis may cycle through repeated courses of antibiotics, with each round buying less time before the next flare.

Trichomonas Vaginalis

Trichomoniasis is often thought of as a vaginal infection, but Trichomonas vaginalis can absolutely infect men and reach the prostate. The parasite attaches directly to the cells lining the prostate, triggering a cascade of inflammatory signals, immune cell migration, and tissue changes including scarring and cell infiltration. In rat studies, infection caused visible pathological damage to prostate tissue, with fibrosis and structural changes that mirror what clinicians see in chronic prostatitis.⁴ Case reports have documented men with persistent urethritis and prostatitis directly caused by Trichomonas, sometimes stubbornly resistant to initial treatment.⁵

One complicating factor is that Trichomonas infections in men frequently produce no obvious symptoms, particularly in the early stages. A man can carry the parasite for months with little more than mild urinary discomfort or nothing at all, while the organism quietly inflames his prostate. This silent damage is part of why some researchers have investigated whether Trichomonas might also contribute to longer-term prostate problems like benign prostatic hyperplasia. A large study looking at PSA levels (a marker sometimes elevated when the prostate is inflamed or enlarged) found that men with high levels of Trichomonas antibodies trended toward slightly higher PSA concentrations than uninfected men, though the difference did not reach statistical significance.⁶ The connection remains suggestive rather than proven, but it highlights how Trichomonas is increasingly taken seriously as a prostate pathogen.

Mycoplasma Genitalium

Mycoplasma genitalium is a relative newcomer to the list of recognized STI pathogens, but evidence linking it to prostatitis has been accumulating. It is a tiny bacterium, one of the smallest capable of independent reproduction, and it tends to cause subtle, hard-to-detect infections. In one evaluation of men attending an STI clinic in China, about 10% of those with clinical prostatitis had Mycoplasma genitalium localized to the prostate, compared to just 3% of asymptomatic controls.⁷ That difference was statistically significant and suggests the organism is not just an innocent bystander picked up during testing.

Mycoplasma genitalium is relevant for another reason: it is notoriously resistant to many standard antibiotics. First-line treatments for other urethral infections often fail against it, and resistance to macrolide antibiotics (the usual go-to drugs) has been rising sharply in many regions. When Mycoplasma genitalium reaches the prostate, this resistance problem gets compounded by the prostate’s own barriers to drug penetration, a topic covered below.

Gonorrhea

Gonorrhea has been associated with prostatitis for over a century. The gonococcus bacterium, Neisseria gonorrhoeae, can cause acute prostatic inflammation during an untreated or inadequately treated urethral infection. Historically, before modern antibiotics were widely available, post-gonorrheal prostatitis was a recognized and relatively common complication. Even after treatment with penicillin and sulfonamides, residual chronic prostatitis was documented in some men who had recovered from acute gonorrhea.²

Today, gonorrhea is treated early enough in most cases that full-blown prostatic involvement is less common than it once was. But incomplete treatment, delayed diagnosis, or antibiotic-resistant strains can still allow the infection to spread from the urethra to the prostate. Given the alarming rise in multi-drug-resistant gonorrhea globally, this is not a purely historical concern.

Herpes Simplex Virus

Viral STIs are less commonly discussed in connection with prostatitis, but herpes simplex virus, particularly HSV-2, has been implicated. Herpes is a neurotropic virus, meaning it lives in nerve cells and can reactivate periodically. Because nerve pathways serving the genitourinary tract run close to the prostate, reactivation of herpes can produce or worsen the chronic pelvic pain characteristic of prostatitis. In men diagnosed with chronic pelvic pain syndrome (a form of prostatitis where no bacteria are found on routine culture), HSV DNA has been detected in urethral specimens.⁸ Herpes simplex virus has also been isolated directly from prostatic fluid in at least one documented case of a man with prostatitis symptoms.⁹

The practical takeaway is that when a man has persistent prostate-area pain and standard bacterial workups come back negative, herpes infection is worth ruling out. This is especially true if the patient has a known history of genital herpes or recurrent outbreaks.

Why These Infections Are Easy to Miss in the Prostate

A significant problem with STI-related prostatitis is that standard testing often fails to pick up the responsible organism. Traditional urine cultures look for common urinary bacteria and will not detect chlamydia, Trichomonas, or Mycoplasma genitalium. Even the classic diagnostic approach for prostatitis, which involves collecting urine samples before and after prostatic massage, has been questioned. A review of the evidence noted that this test has never been adequately validated and whether it meaningfully distinguishes different forms of chronic pelvic pain syndrome is increasingly debated.¹⁰

More sensitive molecular tests, specifically PCR-based assays, dramatically improve detection. In one study of men with chronic prostatitis and urethritis, standard culture methods detected zero cases of Trichomonas, while PCR testing of urine samples identified trichomoniasis in about one in five patients.¹¹ Similarly, when researchers used PCR to screen men with chronic prostatitis who had negative standard cultures and no signs of urethritis, they still found Chlamydia trachomatis, Trichomonas vaginalis, and Mycoplasma genitalium in about 8% of cases.¹² That 8% might sound small, but it represents men who would have been told no infection was present if only routine tests had been performed.

The broader point is that many men diagnosed with “non-bacterial” or “abacterial” prostatitis may actually harbor an STI-related organism that standard methods simply cannot detect. If you have chronic prostatitis symptoms and have never been tested with PCR-based assays for these specific pathogens, the cause of your condition might not truly be “unknown.”

Why STI-Related Prostatitis Is Hard to Treat

Even when the right organism is identified, treating a prostate infection is harder than treating the same organism in the urethra. The prostate gland has its own microenvironment that many antibiotics struggle to penetrate. A systematic review of antibiotic penetration into prostate tissue found that fluoroquinolones consistently achieved good concentrations inside the gland, making them the typical first-line choice. Trimethoprim-sulfamethoxazole showed moderate penetration, while macrolides and tetracyclines had variable but measurable distribution. Most beta-lactam antibiotics, on the other hand, penetrated poorly into non-inflamed prostate tissue.¹³ The factors driving this include the drug’s ability to dissolve in fat, how strongly it binds to blood proteins, and the pH difference between blood and prostatic fluid.¹⁴

For chlamydia-related prostatitis specifically, one comparative trial found that azithromycin significantly outperformed ciprofloxacin. Among 89 men with confirmed chlamydial prostatitis, eradication rates were about 80% with azithromycin versus roughly 39% with ciprofloxacin.¹⁵ That is a dramatic difference and underscores why identifying the specific pathogen matters so much: a drug that works well for one cause of prostatitis may be the wrong tool for another.

Adding to the treatment challenge, some bacteria in the prostate form biofilms, protective colonies encased in a sticky matrix that shields them from antibiotics and the immune system. Research has confirmed that bacterial strains capable of consistent biofilm formation are present in chronic bacterial prostatitis and are associated with prostatic calcifications (small calcium deposits within the gland).¹⁶ Biofilms help explain why some men relapse even after completing a full antibiotic course: the drugs kill the free-floating bacteria but fail to penetrate the biofilm, allowing the infection to bounce back once treatment stops.

Effects on Fertility

STI-related prostatitis does not just cause pain and urinary symptoms. There is growing evidence that it can damage sperm quality. The prostate and other accessory glands contribute fluid to semen, so chronic inflammation in these glands can alter the chemical environment sperm swim through. A study of young men with chronic prostatitis caused by chlamydia found significantly lower sperm concentration, reduced motility, and fewer normally shaped sperm compared to uninfected controls. The researchers identified an immune-mediated mechanism: the body’s antibody response to chlamydial heat shock proteins appeared to damage the sperm-producing cells themselves.¹⁷

The fertility impact may be even worse when multiple STIs are present simultaneously. In a large study comparing young men with prostatitis symptoms who were co-infected with both human papillomavirus and chlamydia to those with prostatitis alone, the co-infected group had significantly lower sperm motility and more abnormal sperm forms. About half of the co-infected men met the threshold for subfertility, compared to about two-thirds of those without co-infection, and the co-infected group had roughly twice the odds of falling below normal semen parameters.¹⁸ A broader review of the literature confirmed that reduced semen quality is a consistent finding in men with chronic prostatitis and chronic pelvic pain syndrome, with several proposed mechanisms including accessory gland inflammation and autoimmune responses.¹⁹

For younger men who might dismiss prostatitis as a manageable nuisance, the fertility connection changes the stakes. Early identification and treatment of any underlying STI is not just about relieving symptoms; it may protect long-term reproductive potential.

HIV and Increased Risk

Men living with HIV face a heightened risk when prostatitis develops, though HIV itself is not typically classified as a direct cause of prostatitis. The issue is that a compromised immune system changes the game. HIV-positive men with prostatitis are at greater risk of developing a prostatic abscess, a pocket of pus within the gland that can require drainage, and of progressing to urosepsis, where the infection enters the bloodstream. Because of this, clinical management differs: longer courses of targeted antibiotics and closer monitoring are generally recommended.²⁰

HIV also creates a scenario where other STIs are more likely to be present and to go undiagnosed. Men with HIV are at higher risk for chlamydia, gonorrhea, and Trichomonas co-infection, all of which can contribute to prostatitis. The interaction runs in both directions: prostate inflammation may increase local viral shedding of HIV, potentially affecting transmission risk, though that area of research is still evolving.

When “Non-Bacterial” Prostatitis Might Actually Be Bacterial

The classification system for prostatitis divides the condition into categories, and the most commonly diagnosed form is chronic prostatitis/chronic pelvic pain syndrome, which by definition means no bacteria have been identified. But as the evidence above illustrates, “no bacteria identified” often just means “no bacteria identified with the tests we ran.” True chronic bacterial prostatitis, where a pathogen is consistently found on culture, is considered uncommon.¹⁰ Yet when researchers apply PCR and other molecular techniques to men in the “non-bacterial” category, they keep finding organisms like chlamydia, Mycoplasma genitalium, and Trichomonas.²¹

This discrepancy raises a legitimate question: how many cases currently labeled non-bacterial are actually infections that standard testing cannot catch? The answer is not fully settled, but the direction of the evidence suggests the number is not trivial. If you have been given a diagnosis of chronic non-bacterial prostatitis and have risk factors for STIs, or if you have a sexual partner who was diagnosed with chlamydia, Trichomonas, or Mycoplasma genitalium, it is worth asking your doctor about molecular testing. The organisms capable of causing prostatitis overlap heavily with the organisms standard cultures routinely miss.

Asymptomatic Infections in Prostate Tissue

One final piece that complicates the picture: infections can exist inside the prostate without producing any symptoms at all. Studies examining prostate tissue from men undergoing surgery for benign prostatic hyperplasia, a condition not typically considered infectious, have found bacterial growth in a substantial proportion of specimens. One study reported bacterial growth in 44% of prostate samples, with catheterized patients showing higher rates of colonization.²² STI-related organisms like chlamydia and Trichomonas have also been found in prostate tissue from men without classic prostatitis symptoms.²

Whether these silent infections are harmless passengers or slow-burning contributors to later prostate problems is still actively debated. Some researchers believe that even asymptomatic STI-driven inflammation in the prostate promotes tissue growth and could contribute to prostate enlargement over time through growth factor secretion and epithelial proliferation. If that connection holds up, it would mean the impact of sexually transmitted infections on the prostate extends well beyond the men who develop obvious symptoms of prostatitis.